Veradermics, INC Schedule 13D activist filings

SR One Capital Management and affiliated entities have filed an amendment to their Schedule 13D, reporting a sale of Veradermics, Inc. common stock and adjusting their beneficial ownership.

Suvretta Capital Management and its affiliates have acquired 300,000 pre-funded warrants in Veradermics, Inc., strengthening their 9.9% stake in the company.

Longitude Capital Partners and associated entities disclosed a 11.3% beneficial ownership stake in Veradermics, Incorporated.

Seven Fleet Master Fund LP has acquired 80,000 shares of Veradermics, Inc., representing a 0.2% ownership stake.

Longitude Capital and its affiliates, including board member Patrick G. Enright, reported a 12.5% beneficial ownership in Veradermics, Incorporated following recent IPO purchases and preferred stock conversions.

Suvretta Capital Management and its affiliated funds have disclosed an 11.9% beneficial ownership stake in Veradermics, Inc., following significant investments including preferred stock conversions, IPO participation, and open market purchases.

SR One Capital Management and affiliated funds have reported a 6.4% beneficial ownership in Veradermics, Inc. following the company's initial public offering and conversion of preferred stock.